<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03477279</url>
  </required_header>
  <id_info>
    <org_study_id>17-0681</org_study_id>
    <secondary_id>R00MH104154</secondary_id>
    <nct_id>NCT03477279</nct_id>
  </id_info>
  <brief_title>Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi</brief_title>
  <official_title>Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi: A Randomized Controlled Trial in Lilongwe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is promising evidence that couple-based approaches within Malawi's Option B+ prevention&#xD;
      of mother to child transmission program could address help address 1) poor male engagement in&#xD;
      the HIV continuum of care, 2) low male adoption of biomedical HIV prevention approaches, 3)&#xD;
      sub-optimal female engagement in the continuum of care, and 4) poor or uncertain infant&#xD;
      outcomes. Our team has developed an intervention to address these challenges, and will&#xD;
      conduct a randomized controlled trial (N=500 couples) to assess intervention effectiveness at&#xD;
      one year. Women with recent HIV infections enrolled in this trial will be compared against a&#xD;
      cohort of 350 HIV-uninfected women to explore predictors of HIV acquisition in pregnancy in&#xD;
      Malawi.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In sub-Saharan Africa, engaging HIV-infected men in HIV care and treatment and engaging&#xD;
      HIV-uninfected men in prevention has proven challenging. Along all steps of the HIV&#xD;
      care-seeking cascade, men exhibit worse care-seeking behaviors. They are less likely to seek&#xD;
      HIV testing and counseling (HTC), initiate combination antiretroviral therapy (cART), and be&#xD;
      retained in cART care. Poor care-seeking has resulted in a lower prevalence of viral&#xD;
      suppression and earlier mortality. Additionally, men rarely engage in the antenatal&#xD;
      care-seeking of their female sexual partners, leading to worse maternal and infant outcomes.&#xD;
      This low level of engagement has been noted in Malawi's Option B+ prevention of mother to&#xD;
      child transmission (PMTCT) program, and has been a critical barrier to female Option B+&#xD;
      uptake and retention, and a missed opportunity for engaging men.&#xD;
&#xD;
      There is promising evidence that couple-based approaches within Malawi's Option B+ prevention&#xD;
      of mother to child transmission program could address all of these challenges: poor male&#xD;
      engagement in the HIV continuum of care, low male adoption of biomedical HIV prevention&#xD;
      approaches, sub-optimal female engagement in the continuum of care, and poor or uncertain&#xD;
      infant outcomes. Our team has designed a couples-based intervention to address these&#xD;
      challenges, and will conduct a randomized controlled trial (N=500 couples) to assess&#xD;
      intervention effectiveness at one year. Results from this study are expected to inform how&#xD;
      best to address family outcomes in an Option B+ program.&#xD;
&#xD;
      This study has the following aims described below:&#xD;
&#xD;
      Aim 1: Determine whether the couple-based intervention increases new HIV-positive diagnoses&#xD;
      among HIV-infected male sex partners, helps HIV-infected men engage and remain in care, and&#xD;
      contributes to male viral suppression compared to individual standard of care. The&#xD;
      investigators will compare the couple-based intervention to standard of care for increasing&#xD;
      the proportion of men who are aware of being HIV-infected, the proportion of these men who&#xD;
      initiate and remain in cART care, and the proportion of these men with viral suppression at&#xD;
      one year.&#xD;
&#xD;
      Aim 2: Determine whether the couple-based intervention identifies HIV-discordant couples and&#xD;
      decreases the likelihood of male exposure to HIV compared to individual standard of care. The&#xD;
      investigators will compare the intervention to standard of care for increasing the number of&#xD;
      men with non-HIV exposure from their female partner through consistent condom use, viral&#xD;
      suppression, abstinence, or a combination of these methods over one year.&#xD;
&#xD;
      Aim 3: Determine whether the couple-based intervention improves female cART retention and&#xD;
      viral suppression compared to individual standard of care. The investigators will compare the&#xD;
      intervention to standard of care for female cART retention and viral suppression at one year.&#xD;
&#xD;
      Aim 4: Determine whether the couple-based intervention improves infant early infant diagnosis&#xD;
      uptake compared to individual standard of care. Explore uptake of early infant diagnosis and&#xD;
      rates of mother-to-child transmission and child survival in the two intervention arms.&#xD;
&#xD;
      Aim 5: Develop an in-depth understanding of HIV transmission dynamics in Lilongwe. Using the&#xD;
      biomarkers and behavioral survey, we will seek to understand transmission timing, direction,&#xD;
      and context in Lilongwe. We will compare women with recent HIV infection to a population of&#xD;
      HIV-uninfected controls (n=350) to understand predictors of HIV acquisition in pregnancy in&#xD;
      Malawi.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 25, 2017</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">July 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Women Retained in Care</measure>
    <time_frame>12 months</time_frame>
    <description>Women who presented at 12 months and reported taking at least one dose of ART in the last seven days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Women With Viral Suppression</measure>
    <time_frame>12 months</time_frame>
    <description>Women who presented at 12 months with a viral load &lt;1000 copies/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of HIV-positive Male Partners Aware of Their HIV-positive Status</measure>
    <time_frame>12 months</time_frame>
    <description>HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of HIV-positive Male Partners Retained in Care</measure>
    <time_frame>12 months</time_frame>
    <description>HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of HIV-positive Male Partners With Viral Suppression</measure>
    <time_frame>12 months</time_frame>
    <description>HIV-positive male partners who presented at 12 months with a viral load &lt;1000 copies/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of HIV-negative Men Without HIV Exposure From Their Primary Partner</measure>
    <time_frame>12 months</time_frame>
    <description>HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis</measure>
    <time_frame>12 months</time_frame>
    <description>HIV-positive female participants who reported a live birth and uptake of early infant diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Predictors of Recent HIV Infection</measure>
    <time_frame>At the day of female consent</time_frame>
    <description>Risk factor analysis to identify predictors of recent HIV infection among pregnant women</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">1116</enrollment>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>Individual (SOC)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>HIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Couple (Intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to receiving standard of care procedures, HIV-infected pregnant women in the couple arm will be provided with an intervention aimed at recruiting their male partners, providing enhanced couple counseling and testing, engaging their male partners in their care, and supporting male partners to receive care and treatment services.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-Uninfected Cohort</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>HIV-uninfected pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enhanced Couple HIV Testing and Counseling</intervention_name>
    <description>Participants are provided study-specific partner referral cards and encouraged to bring male partners to antenatal care for a male engagement intervention. Those who do not present on their own are then traced.&#xD;
Couples will receive three enhanced couple counseling sessions that include: pre-test counseling, return of joint results, and post-test counseling. HIV-infected men will be able to initiate cART at the antenatal clinic and the couple will be offered condoms from the HTC counselor. Between sessions, couple members can pick up condoms and cART for one another.</description>
    <arm_group_label>Couple (Intervention)</arm_group_label>
    <other_name>male engagement intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (HIV-infected Women):&#xD;
&#xD;
          -  HIV-infected and eligible for Option B+&#xD;
&#xD;
          -  &gt;18 years old or 15-17 years old and married&#xD;
&#xD;
          -  Planning to remain in the Bwaila catchment area for the next year or notify the study&#xD;
             team if they leave the area or change facilities&#xD;
&#xD;
          -  Part of a heterosexual relationship for &gt;3 months&#xD;
&#xD;
               -  Expects the partner to be in the relevant catchment area for at least one week in&#xD;
                  the next six months.&#xD;
&#xD;
               -  Able and willing to give locator information for this partner&#xD;
&#xD;
               -  Willing to have study staff conduct phone and physical tracing of that partner&#xD;
&#xD;
               -  Willing to undergo a couple-based intervention with this partner&#xD;
&#xD;
          -  Able and willing to provide informed consent&#xD;
&#xD;
        Inclusion Criteria (Male Partners of HIV-infected women)&#xD;
&#xD;
          -  &gt;18 years old or 15-17 years old and married&#xD;
&#xD;
          -  In a relationship with the female partner for &gt;3 months&#xD;
&#xD;
               -  Willing to undergo a couples-based intervention with their female partner&#xD;
&#xD;
          -  Able and willing to provide informed consent&#xD;
&#xD;
        Inclusion Criteria (HIV-uninfected Women):&#xD;
&#xD;
          -  HIV-uninfected&#xD;
&#xD;
          -  &gt;18 years old or 15-17 years old and married&#xD;
&#xD;
          -  Part of a heterosexual relationship for &gt;3 months&#xD;
&#xD;
               -  Expects the partner to be in the relevant catchment area for at least one week in&#xD;
                  the next six months.&#xD;
&#xD;
               -  Willing to receive couples-based HIV testing and counseling with this partner&#xD;
&#xD;
          -  Able and willing to provide informed consent&#xD;
&#xD;
        Exclusion Criteria (all Women and Male Partners):&#xD;
&#xD;
        â€¢ Any condition that in the opinion of the study investigator would compromise the ability&#xD;
        of the prospective participant to provide informed consent, undergo study procedures&#xD;
        safely, or would prevent proper conduct of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nora E Rosenberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bwaila District Hospital Antenatal Unit</name>
      <address>
        <city>Lilongwe</city>
        <state>Central District</state>
        <country>Malawi</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 19, 2018</study_first_submitted>
  <study_first_submitted_qc>March 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2018</study_first_posted>
  <results_first_submitted>April 30, 2021</results_first_submitted>
  <results_first_submitted_qc>June 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 24, 2021</results_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>couple HIV testing and counseling</keyword>
  <keyword>disclosure</keyword>
  <keyword>Malawi</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/79/NCT03477279/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Individual (HIV+ Women)</title>
          <description>HIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.</description>
        </group>
        <group group_id="P2">
          <title>Couple (HIV+ Women)</title>
          <description>These women will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.</description>
        </group>
        <group group_id="P3">
          <title>Male Partners of Women in Individual</title>
          <description>These men will have access to standard of care procedures.</description>
        </group>
        <group group_id="P4">
          <title>Male Partners of Women in Couple</title>
          <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
        </group>
        <group group_id="P5">
          <title>Control Population (HIV- Women)</title>
          <description>HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="250"/>
                <participants group_id="P2" count="250"/>
                <participants group_id="P3" count="98"/>
                <participants group_id="P4" count="168"/>
                <participants group_id="P5" count="350"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="203"/>
                <participants group_id="P2" count="202"/>
                <participants group_id="P3" count="98"/>
                <participants group_id="P4" count="136"/>
                <participants group_id="P5" count="349"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="48"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="32"/>
                <participants group_id="P5" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Data unreported for 6 surveys that corrupted during upload. Data unavailable for one HIV-negative woman.</population>
      <group_list>
        <group group_id="B1">
          <title>Individual (HIV+ Women)</title>
          <description>HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.</description>
        </group>
        <group group_id="B2">
          <title>Couple (HIV+ Women)</title>
          <description>HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.</description>
        </group>
        <group group_id="B3">
          <title>Male Partners of Women in Individual</title>
          <description>These men will have access to standard of care procedures.</description>
        </group>
        <group group_id="B4">
          <title>Male Partners of Women in Couple</title>
          <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
        </group>
        <group group_id="B5">
          <title>Control Population (HIV- Women)</title>
          <description>HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="246"/>
            <count group_id="B2" value="249"/>
            <count group_id="B3" value="98"/>
            <count group_id="B4" value="167"/>
            <count group_id="B5" value="349"/>
            <count group_id="B6" value="1109"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="246"/>
                    <count group_id="B2" value="249"/>
                    <count group_id="B3" value="98"/>
                    <count group_id="B4" value="167"/>
                    <count group_id="B5" value="349"/>
                    <count group_id="B6" value="1109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="37"/>
                    <measurement group_id="B6" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="231"/>
                    <measurement group_id="B2" value="238"/>
                    <measurement group_id="B3" value="97"/>
                    <measurement group_id="B4" value="167"/>
                    <measurement group_id="B5" value="312"/>
                    <measurement group_id="B6" value="1045"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="246"/>
                    <count group_id="B2" value="249"/>
                    <count group_id="B3" value="98"/>
                    <count group_id="B4" value="167"/>
                    <count group_id="B5" value="349"/>
                    <count group_id="B6" value="1109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="246"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="349"/>
                    <measurement group_id="B6" value="844"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="98"/>
                    <measurement group_id="B4" value="167"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                    <count group_id="B6" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Malawi</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="246"/>
                    <count group_id="B2" value="249"/>
                    <count group_id="B3" value="98"/>
                    <count group_id="B4" value="167"/>
                    <count group_id="B5" value="349"/>
                    <count group_id="B6" value="1109"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="246"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="98"/>
                    <measurement group_id="B4" value="167"/>
                    <measurement group_id="B5" value="349"/>
                    <measurement group_id="B6" value="1109"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Women Retained in Care</title>
        <description>Women who presented at 12 months and reported taking at least one dose of ART in the last seven days</description>
        <time_frame>12 months</time_frame>
        <population>This is an HIV-positive female only outcome. 134 HIV-positive women did not present for the 12 month study visit</population>
        <group_list>
          <group group_id="O1">
            <title>Individual (HIV+ Women)</title>
            <description>HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.</description>
          </group>
          <group group_id="O2">
            <title>Couple (HIV+ Women)</title>
            <description>HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Women Retained in Care</title>
          <description>Women who presented at 12 months and reported taking at least one dose of ART in the last seven days</description>
          <population>This is an HIV-positive female only outcome. 134 HIV-positive women did not present for the 12 month study visit</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="181"/>
                <count group_id="O2" value="185"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="160"/>
                    <measurement group_id="O2" value="164"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.6</ci_lower_limit>
            <ci_upper_limit>7.3</ci_upper_limit>
            <estimate_desc>Couple (HIV+ Women) - Individual (HIV+ Women)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Women With Viral Suppression</title>
        <description>Women who presented at 12 months with a viral load &lt;1000 copies/mL</description>
        <time_frame>12 months</time_frame>
        <population>This is an HIV-positive female only outcome.138 HIV-positive women did not present for the 12 month study visit or did not provide the blood sample required for viral load ascertainment</population>
        <group_list>
          <group group_id="O1">
            <title>Individual (HIV+ Women)</title>
            <description>HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.</description>
          </group>
          <group group_id="O2">
            <title>Couple (HIV+ Women)</title>
            <description>HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Women With Viral Suppression</title>
          <description>Women who presented at 12 months with a viral load &lt;1000 copies/mL</description>
          <population>This is an HIV-positive female only outcome.138 HIV-positive women did not present for the 12 month study visit or did not provide the blood sample required for viral load ascertainment</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="178"/>
                <count group_id="O2" value="184"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="145"/>
                    <measurement group_id="O2" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>6.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.8</ci_lower_limit>
            <ci_upper_limit>14.0</ci_upper_limit>
            <estimate_desc>Couple (HIV+ Women) - Individual (HIV+ Women)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of HIV-positive Male Partners Aware of Their HIV-positive Status</title>
        <description>HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit</description>
        <time_frame>12 months</time_frame>
        <population>This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months</population>
        <group_list>
          <group group_id="O1">
            <title>Male Partners of Women in Individual</title>
            <description>These men will have access to standard of care procedures.</description>
          </group>
          <group group_id="O2">
            <title>Male Partners of Women in Couple</title>
            <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of HIV-positive Male Partners Aware of Their HIV-positive Status</title>
          <description>HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit</description>
          <population>This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>10.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.7</ci_lower_limit>
            <ci_upper_limit>21.7</ci_upper_limit>
            <estimate_desc>Male Partners of Women in Couple - Male Partners of Women in Individual</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of HIV-positive Male Partners Retained in Care</title>
        <description>HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days</description>
        <time_frame>12 months</time_frame>
        <population>This is a male only outcome. 142 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not report information on ART use</population>
        <group_list>
          <group group_id="O1">
            <title>Male Partners of Women in Individual</title>
            <description>These men will have access to standard of care procedures.</description>
          </group>
          <group group_id="O2">
            <title>Male Partners of Women in Couple</title>
            <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of HIV-positive Male Partners Retained in Care</title>
          <description>HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days</description>
          <population>This is a male only outcome. 142 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not report information on ART use</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>16.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>32.3</ci_upper_limit>
            <estimate_desc>Male Partners of Women in Couple - Male Partners of Women in Individual</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of HIV-positive Male Partners With Viral Suppression</title>
        <description>HIV-positive male partners who presented at 12 months with a viral load &lt;1000 copies/mL</description>
        <time_frame>12 months</time_frame>
        <population>This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not provide the blood sample required for viral load ascertainment</population>
        <group_list>
          <group group_id="O1">
            <title>Male Partners of Women in Individual</title>
            <description>These men will have access to standard of care procedures.</description>
          </group>
          <group group_id="O2">
            <title>Male Partners of Women in Couple</title>
            <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of HIV-positive Male Partners With Viral Suppression</title>
          <description>HIV-positive male partners who presented at 12 months with a viral load &lt;1000 copies/mL</description>
          <population>This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not provide the blood sample required for viral load ascertainment</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>15.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.6</ci_lower_limit>
            <ci_upper_limit>31.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of HIV-negative Men Without HIV Exposure From Their Primary Partner</title>
        <description>HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner</description>
        <time_frame>12 months</time_frame>
        <population>This is a male only outcome. 162 did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-positive/indeterminate at 12 months</population>
        <group_list>
          <group group_id="O1">
            <title>Male Partners of Women in Individual</title>
            <description>These men will have access to standard of care procedures.</description>
          </group>
          <group group_id="O2">
            <title>Male Partners of Women in Couple</title>
            <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of HIV-negative Men Without HIV Exposure From Their Primary Partner</title>
          <description>HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner</description>
          <population>This is a male only outcome. 162 did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-positive/indeterminate at 12 months</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="41"/>
                <count group_id="O2" value="63"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-2.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.2</ci_lower_limit>
            <ci_upper_limit>8.5</ci_upper_limit>
            <estimate_desc>Male Partners of Women in Couple - Male Partners of Women in Individual</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis</title>
        <description>HIV-positive female participants who reported a live birth and uptake of early infant diagnosis</description>
        <time_frame>12 months</time_frame>
        <population>This is an HIV-positive female only outcome. For 154 observations, there was no data available on infant outcomes or no live birth</population>
        <group_list>
          <group group_id="O1">
            <title>Individual (HIV+ Women)</title>
            <description>HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.</description>
          </group>
          <group group_id="O2">
            <title>Couple (HIV+ Women)</title>
            <description>HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis</title>
          <description>HIV-positive female participants who reported a live birth and uptake of early infant diagnosis</description>
          <population>This is an HIV-positive female only outcome. For 154 observations, there was no data available on infant outcomes or no live birth</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="171"/>
                <count group_id="O2" value="175"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162"/>
                    <measurement group_id="O2" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-4.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.0</ci_lower_limit>
            <ci_upper_limit>10.7</ci_upper_limit>
            <estimate_desc>Couple (HIV+ Women) - Individual (HIV+ Women)</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Predictors of Recent HIV Infection</title>
        <description>Risk factor analysis to identify predictors of recent HIV infection among pregnant women</description>
        <time_frame>At the day of female consent</time_frame>
        <population>This is a female only outcome. Of the 500 HIV-positive women enrolled into the study, 44 were classified as having recently acquired HIV. Data unavailable for one HIV-negative woman.</population>
        <group_list>
          <group group_id="O1">
            <title>Individual and Couple HIV-positive Women</title>
            <description>A subset of HIV-positive pregnant women enrolled in the individual arm and couple arms of the study with recently acquired HIV infection</description>
          </group>
          <group group_id="O2">
            <title>Control Population (HIV- Women)</title>
            <description>HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.</description>
          </group>
        </group_list>
        <measure>
          <title>Predictors of Recent HIV Infection</title>
          <description>Risk factor analysis to identify predictors of recent HIV infection among pregnant women</description>
          <population>This is a female only outcome. Of the 500 HIV-positive women enrolled into the study, 44 were classified as having recently acquired HIV. Data unavailable for one HIV-negative woman.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="349"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Married to Primary Partner</title>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="338"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Married to Primary Partner</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>4.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.7</ci_lower_limit>
            <ci_upper_limit>13.9</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>For the two groups of HIV-positive women, adverse event data were collected from the signing of the Informed Consent through 1 year afterward. For the two groups of male partners of HIV-positive women, adverse event data were collected from the signing of the Informed Consent through 1 year after consent of their partner.</time_frame>
      <desc>Participants in the Control arm did not receive the study intervention; therefore, adverse event information was not collected.</desc>
      <group_list>
        <group group_id="E1">
          <title>Individual (HIV+ Women)</title>
          <description>HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.</description>
        </group>
        <group group_id="E2">
          <title>Couple (HIV+ Women)</title>
          <description>HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.</description>
        </group>
        <group group_id="E3">
          <title>Male Partners of Women in Individual</title>
          <description>These men will have access to standard of care procedures.</description>
        </group>
        <group group_id="E4">
          <title>Male Partners of Women in Couple</title>
          <description>These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.</description>
        </group>
        <group group_id="E5">
          <title>Control Population (HIV- Women)</title>
          <description>HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="250"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nora Rosenberg, PhD, MSPH</name_or_title>
      <organization>University of North Carolina at Chapel Hill</organization>
      <phone>919-843-6580</phone>
      <email>nora_rosenberg@unc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

